Grifols, Brookfield

Grifols Signals It Would Reject $6.8 Billion Brookfield Bid (3)
Grifols SA’s board recommended that shareholders reject Brookfield Asset Management’s indicative offer, which values the Spanish drugmaker at €6.45 billion ($6.8 billion).
Grifols: Brookfield's potential $6.8 billion offer undervalues the firm
Grifols said on Tuesday that Canadian investment fund Brookfield's potential 6.45 billion euro ($6.8 billion) offer significantly undervalued the Spanish drugmaker's prospects and long-term potential,
Grifols says potential Brookfield offer ‘significantly undervalues’ shares
Grifols (GRFS) informs that its board has held an extraordinary meeting this afternoon “without the intervention of the conflicted board
Grifols linked to €7bn takeover offer from Brookfield
Grifols is anticipating a period of strong growth on the back of its recently FDA-approved intravenous immunoglobulin product Yimmugo, which it expects to become a $1 billion product within the next seven years, as well as a new bi-weekly dosing approval for Xembify and pipeline products fibrinogen and trimodulin.
Brookfield considers US$6.9 billion bid for Grifols; shares dip
Brookfield Asset Management Ltd. is considering a €6.45 billion (US$6.9 billion) bid for Grifols SA, with the drug maker’s board set to meet Tuesday to discuss the potential offer. Grifols’s shares fell.
Brookfield Weighs €6.45 Billion Bid for Grifols; Shares Drop
Brookfield Asset Management is considering a €6.45 billion ($6.9 billion) bid for Grifols SA, with the drug maker’s board set to meet Tuesday to discuss the potential offer. Grifols’s shares fell.
Brookfield mulls $7.4 billion bid for Spain's Grifols, El Confidencial says
Canadian fund Brookfield plans to offer about 7 billion euros ($7.4 billion) for Spanish drugmaker Grifols after finishing due diligence, news website El Confidencial reported on Monday, citing sources close to the matter.
Grifols slips as Brookfield said to mull $6.9B offer
Grifols (GRFS) stock falls as Brookfield Asset Management (BAM) considers a $6.9B offer, which has met with opposition from GRFS' transaction committee. Read more here.
Grifols Board Issues Unfavorable Opinion on Brookfield Offer
Grifols SA’s board of directors said it won’t recommend that shareholders accept Brookfield Asset Management’s indicative ...
Spanish court opens investigation into Gotham City's attack on Grifols
An investigating magistrate at Spain's High Court has opened a probe into U.S.-based short seller Gotham City Research's ...
malaymail5h
Spain court opens probe into ‘misleading’ Gotham City US hedge fund that earned it over €9.4m from pharma’s share sales
A Spanish court yesterday said it was investigating the US hedge fund Gotham City for allegedly publishing “misleading” ...
Mason Capital Reiterates Corporate Governance Shortcomings and Mismanagement of Grifols Under Current Board of Directors
Mason Capital Management LLC ("Mason"), a registered investment advisor to funds and accounts holding approximately 2.1% of ...
Reuters2d
Brookfield mulls $7.4 bln bid for Spain's Grifols, El Confidencial says
Nov 18 (Reuters) - Canadian fund Brookfield (BN.TO), opens new tab plans to offer about 7 billion euros ($7.4 billion) for ...
Grifols doses first patient in Phase 1 trial of GIGA-2339
GigaGen announced that the first patient has been dosed in a Phase 1 clinical trial evaluating the safety and tolerability of the first ...
The Globe and Mail1d
Spanish drugmaker Grifols says Brookfield’s potential €6.45-billion offer undervalues the company
Grifols said on Tuesday that Canadian investment fund Brookfield’s BN-T potential €6.45-billion ($6.8-billion) offer ...
Grifols spikes as banks reportedly finalize offers for buyout debt deal
ADRs gained on Thursday after Bloomberg News reported that several banks are finalizing offers to back nearly €11B ($11.6B) ...